• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Mirum Pharmaceuticals, Inc. - common stock (NQ:MIRM)

    90.09 +0.59 (+0.66%)
    Streaming Delayed Price Updated: 1:24 PM EST, Jan 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 330,324
    Open 90.34
    Bid (Size) 89.79 (200)
    Ask (Size) 90.39 (200)
    Prev. Close 89.50
    Today's Range 88.38 - 90.92
    52wk Range 36.88 - 90.08
    Shares Outstanding 38,297,975
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    A New Era in Rare Hepatology: The Deep-Dive Analysis of Mirum Pharmaceuticals (MIRM)
    Date: January 13, 2026 Introduction Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) has reached a critical inflection point, evolving from a speculative clinical-stage biotech into a commercial-stage... 
    Via PredictStreet
    Topics Economy Initial Public Offering
    News headline image
    3 Top Growth Stocks to Buy in the First Half of 2026 ↗
    Don't wait too long to make a decision on these three stocks. 
    Via The Motley Fool
    Topics Artificial Intelligence

    Performance

    YTD
    +15.4%
    +15.4%
    1 Month
    +40.5%
    +40.5%
    3 Month
    +24.8%
    +24.8%
    6 Month
    +69.1%
    +69.1%
    1 Year
    +104.8%
    +104.8%

    More News

    Read More
    News headline image
    Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) Shows Strong Growth Momentum and Bullish Technical Setup ↗
    Via Chartmill
    Mirum Stock Slips On $820M Bluejay Deal — But Wall Street Calls The Hepatitis Drug Seal A 'Steal' ↗
    Via Stocktwits
    News headline image
    Mirum Director Sells $400K Amid 91% Stock Surge -- Here's What the Firm Expects for 2026 ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline Momentum
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    5 Predictions for the Stock Market in 2026 -- and Which Stocks Will Soar the Most If They're Right ↗
    Via The Motley Fool
    Topics Artificial Intelligence Economy
    News headline image
    Prediction: 3 Stocks That Will Be Worth More Than Newsmax 5 Years From Now ↗
    Via The Motley Fool
    News headline image
    Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Mirum Pharmaceuticals Announces Additional Private Placement Financing With TCGX
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum Pharmaceuticals Enters into Definitive Agreement to Acquire Bluejay Therapeutics, Expanding Global Leadership in Rare Disease
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Prediction: This Stock Has Soared Nearly 70% in 2025 and Will Be an Even Bigger Winner in 2026 ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? ↗
    Via The Motley Fool
    News headline image
    Mirum Pharmaceuticals Announces First Patient Enrolled in the BLOOM Phase 2 Clinical Study Evaluating MRM-3379 in Fragile X Syndrome
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) Shows Strong Growth Momentum and Bullish Technical Setup ↗
    Via Chartmill
    News headline image
    Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45% ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why This Private Equity-Style Fund Just Bet $17 Million on Lumen Technologies Stock ↗
    Via The Motley Fool
    News headline image
    Penn Capital Unwinds $17.1 Million BGC Stake as Broker Posts 31% Revenue Surge ↗
    Via The Motley Fool
    News headline image
    Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD’s The Liver Meeting®
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    What Analysts Are Saying About Mirum Pharmaceuticals Stock ↗
    Via Benzinga

    Frequently Asked Questions

    Is Mirum Pharmaceuticals, Inc. - common stock publicly traded?
    Yes, Mirum Pharmaceuticals, Inc. - common stock is publicly traded.
    What exchange does Mirum Pharmaceuticals, Inc. - common stock trade on?
    Mirum Pharmaceuticals, Inc. - common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Mirum Pharmaceuticals, Inc. - common stock?
    The ticker symbol for Mirum Pharmaceuticals, Inc. - common stock is MIRM on the Nasdaq Stock Market
    What is the current price of Mirum Pharmaceuticals, Inc. - common stock?
    The current price of Mirum Pharmaceuticals, Inc. - common stock is 90.09
    When was Mirum Pharmaceuticals, Inc. - common stock last traded?
    The last trade of Mirum Pharmaceuticals, Inc. - common stock was at 01/13/26 01:24 PM ET
    What is the market capitalization of Mirum Pharmaceuticals, Inc. - common stock?
    The market capitalization of Mirum Pharmaceuticals, Inc. - common stock is 3.45B
    How many shares of Mirum Pharmaceuticals, Inc. - common stock are outstanding?
    Mirum Pharmaceuticals, Inc. - common stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.